Category Archives: Non-U.S. Practice

TRANSMISSION OF INFORMATION IN EUROPE – PATENTABLE SUBJECT MATTER?

By Paul Cole, Lucas & Co., UK The UK counterpart of In re Ngai is Bayer’s (Meyer’s) Application [1984] R.P.C. 11. In that case a claim to a package containing a known drug together with instructions for a new use … Continue reading

Posted in Non-U.S. Practice | Tagged , , , , , , , | Leave a comment

GENERICS (UK) LTD V DAIICHI PHARMACEUTICAL CO LTD – ENANTIOMER OF A KNOWN COMPOUND HELD PATENTABLE BY UK COURT OF APPEAL

By Paul Cole The present dispute concerned the patentability of the enantiomeric quinoline antibiotic levofloxacin covered by Daiichi’s expired EP (UK) 0206283 and by a supplementary protection certificate (SPC) based on it. The racemic compound ofloxacin was known, and the … Continue reading

Posted in Non-U.S. Practice | Tagged , , , , , , , , , | Leave a comment